The Architecture of Contemporary Care Networks for Rare Movement Disorders: Leveraging the ParkinsonNet Experience by Warrenburg, B.P.C. van de et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2021-11-02 and may be subject to
change.
PERSPECTIVE
published: 30 March 2021
doi: 10.3389/fneur.2021.638853
Frontiers in Neurology | www.frontiersin.org 1 March 2021 | Volume 12 | Article 638853
Edited by:
Tobias Warnecke,
University Hospital Münster, Germany
Reviewed by:
Lars Tönges,
University Hospital of the
Ruhr, Germany
Carsten Eggers,
University of Marburg, Germany
*Correspondence:




This article was submitted to
Movement Disorders,
a section of the journal
Frontiers in Neurology
Received: 07 December 2020
Accepted: 08 March 2021
Published: 30 March 2021
Citation:
van de Warrenburg BP, Tiemessen M,
Munneke M and Bloem BR (2021) The
Architecture of Contemporary Care





The Architecture of Contemporary
Care Networks for Rare Movement
Disorders: Leveraging the
ParkinsonNet Experience
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Department of Neurology, Radboud University Medical Centre, Centre of Expertise for Parkinson and Movement Disorders,
Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands
In this paper, we present a universal model for implementing network care for persons
living with chronic diseases, specifically those with rare movement disorders. Building on
our longstanding experience with ParkinsonNet, an integrated care network for persons
living with Parkinson’s disease or a form of atypical parkinsonism, we provide a series of
generic, supportive building blocks to (re)design comparable care networks. We discuss
the specific challenges related to rare movement disorders and how these challenges can
inform a tailored implementation strategy, using the basic building blocks to offer practical
guidance. Lastly, we identify three main priorities to facilitate network development for
these rare diseases. These include the clustering of different types of rare movement
disorders at the network level, the implementation of supportive technology, and the
development of interdisciplinary guidelines.
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INTRODUCTION
Over the past decade, we have witnessed the emergence of care networks for a wide variety of
diseases. Driving forces have been partially externally driven (e.g., governmental or insurance
bodies), but were more often internally motivated, fueled by the conviction among healthcare
professionals that collaboration is key to increase the quality of care. Networks strive to facilitate
access to specialized healthcare workers and supportive services, increase the expertise for specific
conditions, reduce unwanted variations in care practice, and smoothen care coordination. Optimal
collaboration within integrated networks should also boost the experience of care delivery among
healthcare professionals. Building such care networks is in line with theWorld Health Organization
(WHO) global strategy on people-centered and integrated health services and their call for
“integrated health services that are managed and delivered in a way that ensures people receive
a continuum of health promotion, disease prevention, diagnosis, treatment, disease management,
rehabilitation and palliative care services, at the different levels and sites of care within the health
system, and according to their needs throughout their life course.” (1).
A challenge is that the various existing care networks vary greatly with regard to scale (from
local to for example European), focus (single disorder vs. a group of related disorders), extent
of care delivery (some are monodisciplinary, others multidisciplinary, but with a great variety
of disciplines involved), scope, sustainability, level of professionalism, governance structure, etc.
Such variability is explained by many factors. These include financial and infrastructural resources,
density of available experts, frequency of the disease(s) covered, density of the overall population,
specific characteristics of regional or national healthcare systems, and cultural aspects.
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It appears that new initiatives for care networks, well-intended
as they may be, are often either re-inventions of the wheel,
neglecting the opportunity to learn from previous and current
care networks, or duplications of other networks, insufficiently
addressing the question of compatibility with specific aims
and requirements. We here share our view on several generic
principles and ingredients for care networks, which can and need
to be tuned toward the specific network that is being designed and
built. Our view is based on our rich experience with the Dutch
ParkinsonNet approach, which we will introduce first. We will
then discuss a framework of generic aims and strategies of care
networks, as well as the specific challenges related to networks
that target rare (movement) disorders.
PARKINSONNET—HISTORY, MERITS, AND
LESSONS LEARNED
The Dutch ParkinsonNet is a multidisciplinary professional
network that aims to improve the quality of care delivery
for patients with Parkinson’s disease (PD) or a form of
atypical parkinsonism (2, 3). The network consists of a
limited number of specifically trained healthcare professionals
(every participant has received an intensive 3-day baseline
training course according to the latest guidelines), who attract
a high caseload and thereby continuously improve their
Parkinson-specific expertise. The network started in 2004 in the
Netherlands, motivated by two concurrent developments. The
first motivations came directly from clinical practice, where there
was a widely felt need for an easily accessible community-based
network of allied health professionals with dedicated expertise in
treating patients with PD (4). This disorder is characterized by a
wide range of motor and non-motor symptoms, many of which
respond insufficiently to symptomatic pharmacotherapy (5).
Allied health interventions such as physiotherapy, occupational
therapy or speech-language therapy can potentially treat many
of these otherwise treatment-resistant symptoms, in particular
in light of the underlying pathophysiology: basal ganglia
dysfunction in PD leads to loss of automated movements, but
this can be bypassed using a range of compensatory strategies,
such as cueing strategies to improve gait, or specific strategies to
improve the intelligibly of speech (6). However, optimal delivery
of such interventions requires a good understanding of both the
complex clinical presentation and underlying pathophysiology
of PD, as well as knowledge of specific treatment strategies. At
the time, it was impossible to initiate a dedicated referral to a
motivated allied health professional who sufficiently understood
PD and who had considerable experience in treating PD patients.
Some professionals have built up rich expertise in their daily
practice, but they are not readily retrievable in the “yellow pages”
of PD. And even when such professionals can be found, it
was very difficult to initiate an integrated and multidisciplinary
treatment for patients, because most professionals knew very
little about what other professional disciplines had to offer
(7), and easy communication channels were lacking. A
network approach was felt to be an appropriate solution for
these challenges.
The second motivation was the need to build a better
evidence-base for the various allied health interventions in the
field of PD. Although allied health interventions were widely
considered to be potentially useful therapies for PD, robust
scientific evidence to support the merits of these approaches
was lacking. Performing clinical trials was deemed to be a
risky enterprise, because at the time, allied health professionals
had received very little Parkinson-specific training as part
of their routine educational programs, and also treated very
few patients in their daily practice annually. Having such
poorly experienced providers as the deliverers of care in an
intervention trial carried an enormous risk of creating a false-
negative result. This further motivated the installation of a
network of initially only specifically trained physiotherapists,
who were trained according to a newly developed practice-
based guideline. This created the necessary infrastructure for
subsequent clinical trials.
The first ParkinsonNet network was launched in the eastern
part of the Netherlands, and consisted of a small and
selected group of healthcare professionals from three different
professional disciplines (physiotherapy, occupational therapy,
speech-language therapy) (8). All participants were trained
according to practice-based evidence guidelines, and were also
educated about the offerings of the other professional disciplines.
Using simple brochures, referring physicians were informed
about the presence of these specifically trained professionals,
allowing a dedicated referral and a subsequent increase in
caseload. Following positive experiences with this initial small
regional network (8), eight further networks were launched
in different regions of the Netherlands, consisting initially of
only specifically trained physiotherapists, with the aim of using
this infrastructure for a subsequent cluster-controlled trial (9).
Eight other comparable regions initially served as controls, but
following the positive outcome of the trial, these regions also
received a professional physiotherapy network. In subsequent
years, the network was extended both geographically (reaching
a full nationwide coverage by the year 2010), and also in terms
of numbers of attached professional disciplines. The network
currently exists of over 3,400 specifically trained healthcare
professionals, from now 19 different professional disciplines (not
only allied health, but also dieticians, Parkinson nurses, social
workers, etc.). The active “ingredients” of the ParkinsonNet
approach are summarized in Table 1.
The merits of this network approach have subsequently been
evaluated in a series of clinical studies, including both carefully
controlled trials (9–12) and large-scale uncontrolled analyses
of a national medical claims database (13). Taken together,
these studies provided consistent and converging evidence that
supports the cost-effectiveness of a network approach, which
appears to be mediated by an improved care delivery (3): the
knowledge and use of professional guidelines has enhanced; the
caseload of the network participants has increased significantly,
not only initially, but the concentration of care continues to
improve over the years (14); professionals are much better
aware of what other disciplines in the network potentially have
to offer; interdisciplinary collaboration has improved; health
outcomes are better for patients treated within the network,
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TABLE 1 | Overview of the supportive building blocks of care networks, including a detailed description and examples of how these have been implemented in
ParkinsonNet.
Building blocks Description The way ParkinsonNet implemented this
Selection and
certification
A selection process combined with a baseline training leads to
selective inclusion of motivated and specifically trained healthcare
providers. Periodic re-certification based on quality criteria is
important to guarantee a high-quality expert network.
• Each year, ParkinsonNet includes new healthcare professionals in the
network. In each region we strive to reach an appropriate number
of allied health professionals. The required number depends on the
discipline and the geographic area.
• ParkinsonNet requires members to treat a minimum number of PD
patients each year.
• Members commit to work according to evidence-based guidelines.
• Every 2 years a mandatory re-certification is required based on
quality-of-care criteria.
Support centre An overarching support centre that supports regional networks of
providers to work together to improve regional healthcare delivery.
• A national ParkinsonNet coordination centre that provides active
guidance to 71 ParkinsonNet regional networks and >3,400
ParkinsonNet healthcare professionals.
◦ Supporting regional networks with personal advice
◦ Financial support to organize regional meetings
◦ Sharing best practices among regional networks





Guideline development is a solid base for healthcare improvement,
both to improve quality of care in daily practice and as important
basic training material. Guideline development alone is not
enough. It is crucial to support healthcare professionals to work in
accordance with guidelines. Accessible guidelines -possibly with
some decision support – are a prerequisite for achieving this.
Together with several associations for healthcare professionals, and
with the Parkinson Patient Association, ParkinsonNet has developed
guidelines:
• Monodisciplinary guidelines for physiotherapy, speech-language
therapy, occupational therapy, dietary issues, Parkinson’s disease
nurses and palliative care.
• A multidisciplinary guideline, including a consensus-based model for





To become an ‘expert’, healthcare professionals should participate
in continuous learning cycles, including interaction and information
exchange between providers.
• Eligible members must follow a baseline PD-specific training
according to evidence-based guidelines (3 days).
• After completing this training it is crucial to start learning on the job;
expertise can only be increased by treating many patients and by
discussing the treatment of complex patients with other health care
professionals
• Multiple specific trainings, for example about cognition and palliative
care
• Multiple short animated videos about topics as 10 tips for carers and
psychosocial care
• Annual conferences
• Regional interdisciplinary meetings (twice a year)
• Participation in web-based national and regional online communities
Online and offline
meetings
Regularly meeting other professionals is important to learn from
each other, to inspire each other and to facilitate contact between
professionals when this is needed to discuss the treatment
strategy for individual patients within a multidisciplinary team.
• Network participants must meet each other in their own region at least
twice a year
• National annual conference (to learn and meet other professionals)





Patients should be able to readily find and access specialized
experts.
• Providing a web-based search engine (www.ParkinsonZorgzoeker.nl)




Key to patient empowerment is education of patients and the
behavior of providers within the individual patient-provider
relationship.
• National level:
◦ Strategic partnership with Dutch Parkinson Patient Association
◦ Advisory patient panel for novel technologies or other innovations
◦ Patient representation at regional and national conferences
◦ Educational web-based television program (www.parkinsonTV.nl)
◦ PD management guideline in lay language for patients
◦ Website with reliable information about ParkinsonNet
(www.ParkinsonNet.nl)
• Regional level:
◦ Collaboration with local branches of Parkinson Patient Association
• Individual patient-provider relationship:
◦ Training participating providers to engage patients as partners
in healthcare
◦ Promoting shared decision making
(Continued)
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TABLE 1 | Continued





Continuous evaluation and improvement of the network is key.
Transparency about performance indicators is also important to
inform stakeholders about the merits of the network.
Insight into:
• Quality (e.g. adherence to guidelines)
• Outcomes (e.g. complications)
• Costs
• Average caseloads of network participants
• Utilization of the network by patients
• Experiences of healthcare professionals
• Experiences of patients
Health care insurance data and surveys among network participants




Technology can support interdisciplinary collaboration within the
network of each individual patient, and also within regional or
national networks of health care professionals.
• ParkinsonConnect, a web-based community tool that enables easy




including a marked reduction in hip fractures and hospital
admissions for orthopedic injuries or aspiration pneumonia;
and healthcare costs have reduced significantly, as a result of
both prevented disease complications and a greater efficiency
of care (ParkinsonNet professionals require significantly fewer
treatment sessions to achieve their treatment goals). One study
even showed a tendency toward a lowermortality rate for patients
receiving network care, presumably because of the prevented
disease complications (13).
The scientific publications that documented these positive
outcomes stirred a fast rising international interest in building
similar networks for Parkinson patients in other countries. We
have meanwhile introduced comparable networks in, among
others, United States (a partnership with Kaiser Permanente
in California, and a network in Rochester), Norway and
Luxembourg, while additional trainings are currently taking
place or are being planned in Germany, Italy and China. An
important lesson learned from this international experience is
that the networks in other countries each time have to be adjusted
to the local needs, as well as to the existing infrastructure and
available services. Supporting other countries in building similar
networks was all but a “copy paste” enterprise, but instead
was always preceded by a careful inventory of what existing
services were already operating well, which challenges existed
regionally, and which of the solutions offered by ParkinsonNet
could help to address these existing challenges. A further
important lesson was that each international network is to
be governed by regional leadership, and that it is essential to
locally train “super experts” for each associated professional
discipline, so these can subsequently oversee the quality of the
regional network in the other country. Capitalizing on these
lessons, the initial experience with the international network in
California has been very positive, showing a significant change
in referral patterns toward the specifically trained ParkinsonNet
participants (15).
We previously already alluded to the opportunity to
consider ParkinsonNet as a scalable model for other chronic
conditions, including other movement disorders (3). The
management of these disorders is equally challenged by
very comparable issues such as lack of specific expertise,
care fragmentation, and insufficient collaboration between
disciplines. These challenges are presumably even more
prominent for rare disorders, for which dedicated expertise
and optimal collaboration with fellow peers in the expert
network is presumably extra important. Most of the key
components of ParkinsonNet can be considered as generic
ingredients (“building blocks”) for care networks, although
the specific requirements for each professional network will
undoubtedly have to be adjusted to the unique needs of each
condition as well as the specific regional circumstances. Next,
we will discuss these generic ingredients, which we refer to
as supportive building blocks, according to the why, how and
what principles.
SUPPORTIVE BUILDING BLOCKS OF
CARE NETWORKS
Why?
The ultimate objective of the integrated network care model
is to reach the quadruple aim of healthcare, with (1) better
health outcomes, (2) lower cost of care, (3) improved patient
experience, and (4) improved staff experience (Figure 1). To
reach this quadruple aim, the model focuses on four concrete
goals: (1) patients should always receive personalized treatments,
(2) care is delivered by professionals with adequate specific
expertise for the disease at hand (specialized experts), (3)
experts from different disciplines and organizations should work
together with other professionals within interdisciplinary teams
(interdisciplinary care), and (4) patients should be seen as real
partners in the healthcare process, and be supported to make
an active contribution to their own health (patient engagement).
These driving forces are in line with the values of integrated
care identified by Zonneveld et al. (16) in their systematic
review that aimed to identify factors that drive behavior,
decision-making, collaboration and governance processes within
integrated care networks.
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FIGURE 1 | Proposed universal model for integrated network care.
How?
Central to the model that we present here is a managed
multi-level network. In this network approach, patients and
professionals from different disciplines and organizations work
closely together in different networks and at different levels,
in order to improve the quality of care for all patients with
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the same disease in a certain geographical area. In this regard,
it is good to realize that the word “network” is often used to
denote various forms of collaboration at very different scales.
The smallest scale of a network is formed by the healthcare
team that is involved in the management of any given individual
patient. To provide a concrete example, the neurologist, nurse,
physiotherapist, dietician and general practitioner together from
the personal care network of Mr. Johnson. But networks also
exist at a larger scale. Specifically, at a higher level, larger
numbers of healthcare professionals, all with dedicated expertise
in the same disease, can meet each other in local, regional
or national networks, not so much to provide care to an
individual patient, but rather aiming to learn from each other
and to agree about regional healthcare management issues (for
example, do we have a sufficient number of specifically trained
physiotherapists to optimally manage the population within this
specific geographical area?). The geography of these networks
depends on the incidence of a disease. For diseases with a high
prevalence, regional or even local networks of professionals can
be formed. For diseases with a much lower incidence, these
networks can be organized at a state or national level. The
members of the regional networks should ideally be supported
by a national support center, which provides among others
generic support and advice to the various regions. Patients,
professionals and teams are empowered by this support center
with a range of activities to reach the three goals. The most
important activities are described as the building blocks in the
“what-section.” In the building process of the care network,
four development phases of integrated care can be followed:
“initiative and design phase,” “experimental and execution
phase,” “expansion and monitoring phase,” and “consolidation
phase.” These phases have been described and validated by
Minkman et al. (17, 18).
What?
The generic building blocks to organize the network and to
empower patients, professionals and teams are presented in
Table 1. This overview of building blocks is not inclusive, and
the building blocks can differ between diseases, and will also
depend on the specific regional circumstances, including the
characteristics of the healthcare system. For example, in the
aforementioned collaboration between the Dutch ParkinsonNet
and Kaiser Permanente in California, a decision was reached to
use only a restricted number of building blocks (e.g., guideline
development, professional training, patient empowerment),
whereas others were deemed to be unnecessary (e.g., use
of some of the supporting digital technologies, since these
were already available as part of the Kaiser Permanente
offerings) (15).
SPECIFIC INGREDIENTS AND
CHALLENGES FOR RARE MOVEMENT
DISORDERS
Themain challenges for networks that focus on rare disorders are
obviously related to the rarity of each of the individual conditions.
There are estimated to be 600–800 different rare diseases, each
with individually low prevalence rates. We should therefore not
strive to have specifically dedicated networks for each of the
rare movement disorders separately, also because there are often
mixed types of movement disorders in these conditions (for
example, many patients with a hereditary ataxia may present with
additional movement abnormalities, such as dystonia or chorea).
As expertise results not only from having received a
baseline training but also to a large extent from accumulating
experience in daily clinical practice, a sufficient exposure
to large numbers of patients with a certain condition is
required. This clearly necessitates efforts to centralize the
care for specific conditions among a restricted number of
specifically trained professionals. The concentration of care was
a successful cornerstone of the ParkinsonNet approach, but
this will presumably be at least as important for networks
focusing on rare movement disorders. In this regard, it is a
promising development to see the presence of an increasing
number of expert centers for rare disorders (sometimes self-
proclaimed, but increasingly also formally recognized according
to established objective criteria) inmany countries. In accordance
with our ideas about the supportive building blocks (Table 1),
such experts centers would be ideally positioned to take
on the role of support centers when new networks are
being formed.
To be designated as an expert center by national authorities
requires that various predefined criteria have to be met, which
serve a quality control purpose. These criteria should address
relevant issues such as minimal patient numbers, optimal
team size and composition, research performance, and other
tangible metrics. A next step would be to evaluate these centers
based on actual patient-relevant performance measures, but
such quality-of-care criteria remain to be established for rare
movement disorders.
In the Netherlands, we have seen a steep rise in the number
of expert centers, sometimes even for a single rare disease.
As a response, future applications should target clusters of
rare diseases in order to obtain a formal recognition by the
Ministry of Health. Such clustering can be reached at various
levels, such as a comparable etiology, overlapping functional
deficits, or similarities in treatment. This clustering also serves
to achieve a certain caseload, which is needed to develop,
maintain and ultimately expand the required level of expertise.
Clustering could lead to a dilution of expertise for single
disease entities, but the advantages and necessity hereof outweigh
this potential disadvantage. Moreover, one could argue that
recognizing the overlap between and co-existence of multiple
movement disorders—which is more likely secured in centers
that host clusters—actually aids the disease-specific expertise.
One example of how clusters for rare movement
disorders could look like, are those that have been
proposed within the European Reference Network for Rare
Neurological Diseases (ERN-RND; see contribution by (19);
doi: 10.3389/fneur.2020.616569). This network has a strong focus
on rare movement disorders, and has used (1) cerebellar ataxias
and hereditary spastic paraplegias, (2) Huntington’s disease
and other choreas, (3) dystonia, paroxysmal disorders, and
neurodegeneration with brain iron accumulation, (4) atypical
parkinsonian syndromes as the four main clusters.
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Ideally, all patients with rare movement disorders should
be seen, at least once, in expert centers, in particular to
establish a definitive diagnosis whenever possible, and to outline
the contours of a therapeutic management program for the
following years. However, this will not always be possible,
for example because of long travel distance and costs or
patient immobility, or simply because of insufficient capacity.
Additionally, lack of awareness of the presence of centers of
expertise further hampers a dedicated referral to these centers.
Realizing that physical consultations are not always feasible, we
feel that an important task of such an expert center within
the network structure is to transfer knowledge and skills to
local healthcare professionals working close to the patients’
home. Many patients prefer to be (also) followed up by their
local neurologist, and from studies in the PD field we now
know that neurologists who work in community hospitals
deliver better quality care for patients if they are supported
remotely by an expert via telemedicine (so-called peer-to-peer
consultations) (20).
One of the main challenges in the allied health domain is to
identify professionals who are indeed motivated to be equipped
with greater knowledge and better skills for a specific rare
disease, of which the total number of patients in their practices
will remain extremely low. This is in clear contrast with the
original ParkinsonNet model, where trained participants in the
network have witnessed a very tangible increase in the number
of patients with PD in their daily practice. This notion raises
the question where for example allied healthcare interventions
should be delivered best. This could still a local trained therapist,
but may also very well be a rehabilitation facility as close
as possible to the patient. Regardless of the scenario, well-
designed and preferably evidence-based guidelines are needed.
For rare movement disorders, such guidelines are often lacking,
particularly for non-pharmacological interventions. The absence
of such guidelines—a crucial building block in the model we
present here—makes it very difficult to have local professionals
execute an intervention proposed by an expert center. Having
guidelines is also essential as baseline training materials for
professionals who wish to join a professional network, and to
help reduce unwanted variations in care delivery. For some of
these guidelines, particularly those that involve rehabilitation,
one will need to consider clustering at the level of shared or
overlapping movement disorders, as eluded to earlier. This has
also been done in ParkinsonNet, where professionals now deliver
care to both PD and atypical parkinsonism patients. A treatment
guideline for ataxia will benefit patients with MSA-c and
Freidreich’s ataxia alike, while separate guidelines will prevent
professionals to become acquainted with the commonalities in
symptoms, functional deficits, and treatment principles. Some
recent studies on rehabilitation in for example ataxia and cervical
dystonia will be useful starting points for the development of
such guidelines, which should have priority for rare movement
disorders (21, 22).
The quality of care provided by expert (and support) centers
will be improved further if there is between-center collaboration
and knowledge exchange. To achieve this, cross-state and
international networks of expert centers have been established,
e.g., the European Reference Networks (ERN). By demanding
clustering, the European Union wisely prevented the emergence
of too many networks that deal with a single or limited set
of diseases. One of the ERN’s specifically addresses the cluster
“rare neurological disorders” (ERN-RND; see contribution by
Reinard et al. in this series), including movement disorders.
This development offers opportunities to widely harmonize
disease management, to deliver cross-border care, to provide
access to facilities to low-resource countries, and to draft
joint research programs. While advantages are omnipresent,
such international networks do, however, also add layers of
complexity, such as reimbursement issues for cross-border care,
complex network governance, and asymmetry in knowledge
and resources that prevent guideline harmonization. An elegant
solution to provide cross-border care, or at least get access to
an international panel of experts, is provided by an IT-platform
that the European Union has installed for ERN’s, in harmony
with “supportive technology” identified by us as one of the
building blocks.
CONCLUDING REMARKS
Based on our experience with ParkinsonNet, a network for
integrated care in PD, we have here shared our view on
a universal model for care networks. We have presented
supportive building blocks of such a network, which are generic
ingredients that ultimately allow the network to reach the
quadruple aim of healthcare. The rarity of various movement
disorders imposes certain unique challenges and barriers that
prevent a full and immediate adoption of the model as laid
down here. However, our view on the generic ingredients can
serve as the starting point for shaping a new care network.
Also, existing networks and centers that are part of these
networks can identify which building block(s) they wish to
adopt or improve, which can be jointly and transparently
prioritized. Ideally, innovations such as care networks should
be tested against current standards of care and demonstrate
added benefit and/or cost-effectiveness. We appreciate that this
will be a challenge on its own for cross-border networks for
rare disorders.
For rare movement disorders, it seems that three aspects
have priority. First, clustering of rare movement disorders at
the network level is needed, not only to identify the expert
professionals and centers, but also to ensure a certain caseload
and to exploit the fact that specific care interventionsmay overlap
across different conditions. Second, supportive technology is a
true necessity in order to facilitate exchange of and access to
knowledge and expertise. Technological solutions are particularly
important, because the density of experts and expert centers for
rare movement disorders is low in most regions and countries,
so physical in-person meetings are difficult to organize. In
fact, the many challenges imposed by the unfolding COVID-
19 crisis have only further helped to accelerate the introduction
of telemedicine solutions to ascertain a good quality of care
delivery for people living with chronic neurological conditions
(23). Lastly, interdisciplinary guidelines need to be developed,
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as these are quite central to the model, facilitating training of
professionals, harmonizing care, and evaluating performance of
professionals, centers and the network.
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